Antitubercular inhaled therapy: opportunities, progress and challenges (Q36068001)

12 August 2017

1 reference

title

Antitubercular inhaled therapy: opportunities, progress and challenges (English)

1 reference

12 August 2017

Rajesh Pandey

1 reference

12 August 2017

G K Khuller

series ordinal

1 reference

12 August 2017

language of work or name

English

0 references

publication date

10 March 2005

1 reference

Journal of Antimicrobial Chemotherapy

12 August 2017

published in

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

page(s)

430-435

1 reference

A history of nebulization

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

TB drug discovery: addressing issues of persistence and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Risk of tuberculosis among healthcare workers: can tuberculosis be considered as an occupational disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

A review of the technical aspects of drug nebulization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Macrophage specific drug delivery in experimental leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Liposome technology for drug delivery against mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Liposomal aerosols in the management of pulmonary infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Nebulization of liposome encapsulated antitubercular drugs in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Polymer based drug delivery systems for mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Airways delivery of rifampicin microparticles for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Programmes and principles in treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Direct lung delivery of para-aminosalicylic acid by aerosol particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Production and characterization of a budesonide nanosuspension for pulmonary administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

PLGA nanoparticles in drug delivery: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Production of solid lipid nanoparticles (SLN): scaling up feasibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI027

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI027

1 reference

12 August 2017

1 reference